Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution.

H Kobayashi, H Hidaka, Y Kajiya, P Tanoue, H Inoue, K Ikeda, M Nakajo, S Shinohara
{"title":"Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution.","authors":"H Kobayashi,&nbsp;H Hidaka,&nbsp;Y Kajiya,&nbsp;P Tanoue,&nbsp;H Inoue,&nbsp;K Ikeda,&nbsp;M Nakajo,&nbsp;S Shinohara","doi":"10.1177/028418518602700203","DOIUrl":null,"url":null,"abstract":"<p><p>Transarterial injection of modified iodized oil was performed in 48 patients with hepatoma. In 41 cases an adriamycin and/or mitomycin C-iodized oil suspension was administered into the proper hepatic artery or peripheral hepatic branches. A reduction in tumor size of over 50 per cent was obtained in 14 of the 33 patients in whom CT examination was performed before and after treatment. Serum alpha-fetoprotein levels decreased in 20 of 21 cases within the first month after injection. The one-year survival rate was estimated at 55 per cent in advanced hepatoma. In 7 patients, transarterial internal irradiation using radioactive iodized oil was carried out. A decrease in tumor size was observed in all cases and in alpha-fetoprotein levels in 6 cases. One patient with severe liver cirrhosis died in hepatorenal failure. No severe complications or other adverse reactions were encountered with either of the methods.</p>","PeriodicalId":7142,"journal":{"name":"Acta radiologica: diagnosis","volume":"27 2","pages":"139-47"},"PeriodicalIF":0.0000,"publicationDate":"1986-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/028418518602700203","citationCount":"87","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta radiologica: diagnosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/028418518602700203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 87

Abstract

Transarterial injection of modified iodized oil was performed in 48 patients with hepatoma. In 41 cases an adriamycin and/or mitomycin C-iodized oil suspension was administered into the proper hepatic artery or peripheral hepatic branches. A reduction in tumor size of over 50 per cent was obtained in 14 of the 33 patients in whom CT examination was performed before and after treatment. Serum alpha-fetoprotein levels decreased in 20 of 21 cases within the first month after injection. The one-year survival rate was estimated at 55 per cent in advanced hepatoma. In 7 patients, transarterial internal irradiation using radioactive iodized oil was carried out. A decrease in tumor size was observed in all cases and in alpha-fetoprotein levels in 6 cases. One patient with severe liver cirrhosis died in hepatorenal failure. No severe complications or other adverse reactions were encountered with either of the methods.

碘油悬浮液或放射性碘油溶液经动脉注射抗癌药物治疗肝细胞癌。
本文对48例肝癌患者行改良碘化油经动脉注射治疗。在41例患者中,阿霉素和/或丝裂霉素c碘化油混悬液被注入肝固有动脉或肝外周分支。在治疗前后进行CT检查的33名患者中,有14名患者的肿瘤大小缩小了50%以上。21例患者中有20例在注射后1个月内血清甲胎蛋白水平下降。晚期肝癌的一年生存率估计为55%。7例患者行放射性碘化油经动脉内照射。所有病例肿瘤大小均减小,6例甲胎蛋白水平降低。1例严重肝硬化患者死于肝肾衰竭。两种方法均未发生严重并发症或其他不良反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信